Alzheimer's Mouse Models KOMP2 Phenotyping

$354,291UM1FY2019HGNIH

Baylor College Of Medicine, Houston TX

Investigators

Linked publications & trials

Paper 39349521 Paper 39253977 Paper 39126705 Paper 38960317 Paper 38956430 Paper 38709635 Paper 38685607 Paper 38545656 Paper 38523431 Paper 38464671 Paper 38438248 Paper 38414863 Paper 38373689 Paper 38260363 Paper 37961647 Paper 37937642 Paper 37880260 Paper 37786382 Paper 37773757 Paper 37708408 Paper 37691128 Paper 37538440 Paper 37486182 Paper 37377039 Paper 37301944 Paper 37294348 Paper 37154033 Paper 37066295 Paper 37012319 Paper 36977593 Paper 36844399 Paper 36737727 Paper 36711878 Paper 36595694 Paper 36595063 Paper 36587842 Paper 36456625 Paper 36379210 Paper 36229886 Paper 36125045 Paper 36065636 Paper 35972048 Paper 35741020 Paper 35708026 Paper 35562082 Paper 35552317 Paper 35263593 Paper 35188328 Paper 35034472 Paper 34914687 Paper 34610308 Paper 34571923 Paper 34504808 Paper 34489478 Paper 34450031 Paper 34429321 Paper 34274354 Paper 34061437 Paper 33974562 Paper 33854880 Paper 33843195 Paper 33833456 Paper 33772019 Paper 33762728 Paper 33497365 Paper 33373331 Paper 33370286 Paper 33369125 Paper 33277471 Paper 33193060 Paper 32832873 Paper 32719538 Paper 32552404 Paper 32542000 Paper 32504080 Paper 32320644 Paper 32008577 Paper 32005800 Paper 31949211 Paper 31609468 Paper 31591642 Paper 31338999 Paper 31265437 Paper 31257132 Paper 31195428 Paper 31175897 Paper 31170414 Paper 31127358 Paper 31067451 Paper 30811446 Paper 30773489 Paper 30773277 Paper 30692144 Paper 30655341 Paper 30612588 Paper 30521848 Paper 30395363 Paper 30371314 Paper 30177747 Paper 30157441

Abstract

The goal of this supplement is to provide funds to bridge mouse line production from our currently funded period into the prospective next phase. The available funds for production in year five are dedicated to completing generation of the tm1b lines and their expansion for phenotyping. There is no provision for mouse production in year five of our currently funded award to generate new mouse lines for phenotyping. The supplement will provide additional funding to generate new mouse lines during year five, in advance of the prospective year six continuation, ensuring continuity of well developed production pipelines and an uninterrupted supply of lines for phenotyping. This supplement will also support needed development to resolve optimal approaches to producing CRIPSR conditional alleles at scale, as well as extending production as possible to reporter alleles. Our need for this supplement relates entirely to the requirement for additional funding necessary to support this production and development; it is not feasible to carry out this activity within the existing award.

View original record on NIH RePORTER →